CVE-2026-31278 supremainc CVE debrief

Who should care

Defenders responsible for Suprema BioStar 2 and BioStar X systems, especially those exposed to the internet or used in sensitive environments, should assess their exposure and prioritize mitigation.

Why it matters

CVE-2026-31278 is a high-severity vulnerability in Suprema BioStar 2 and BioStar X that allows attackers to obtain Active Directory service account credentials in cleartext. Defenders should prioritize verifying and mitigating the vulnerability, especially in sensitive environments.

• Potential exposure of Active Directory service account credentials.
• Possible lateral movement or privilege escalation.
• Required verification of vulnerable versions and systems.
• Potential impact on sensitive environments or systems.

Technical summary

A vulnerability in the /api/v2/setting/adserversetting endpoint of Suprema BioStar 2 before 2.9.12 and BioStar X before 1.0.2 allows attackers to obtain Active Directory service account credentials in cleartext by supplying a crafted GET request. This high-severity vulnerability can lead to potential exposure of Active Directory service account credentials, possible lateral movement or privilege escalation, and required verification of vulnerable versions and systems. Defenders should prioritize verifying and mitigating the vulnerability, especially in sensitive environments.

Defensive priority

Defenders should prioritize verifying and mitigating the vulnerability in Suprema BioStar 2 and BioStar X systems, especially those exposed to the internet or used in sensitive environments.

Recommended defensive actions

• Verify the versions of Suprema BioStar 2 and BioStar X systems in your environment and check if they are vulnerable.
• Implement compensating controls to protect Active Directory service account credentials.
• Monitor for potential exploitation attempts and anomalous activity.
• Apply patches or updates as available from the vendor.
• Review compensating controls for exposed systems while remediation is scheduled and verified.
• Check relevant monitoring, detection, and logs for exposed assets that need extra review.
• Track exceptions, retest remediated assets, and close the item only after evidence is documented.

Evidence notes

The CVE record and NVD entry provide details about the vulnerability in Suprema BioStar 2 and BioStar X. However, the scope of affected versions and systems requires further verification. Defenders should review the official advisory and CVE record to validate affected scope, severity, and vendor guidance. The vulnerability allows attackers to obtain Active Directory service account credentials in cleartext by supplying a crafted GET request. Evidence is limited to CVE and NVD details; additional verification is needed.

Sources and references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.